NOVT

Novanta Inc

NOVT, USA

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.

https://www.novanta.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NOVT
stock
NOVT

Novanta Revises Q4 2025 Financial Guidance Post Equity Issuance MSN

Read more →
NOVT
stock
NOVT

Novanta Inc. $NOVT Shares Sold by Axa S.A. Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$154

Analyst Picks

Strong Buy

1

Buy

2

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

76.36

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

5.42

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

1.33 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.71 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

1.70 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

0.88

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 105.53% of the total shares of Novanta Inc

1.

BlackRock Inc

(12.5919%)

since

2025/06/30

2.

Vanguard Group Inc

(11.635%)

since

2025/06/30

3.

T. Rowe Price Associates, Inc.

(5.2001%)

since

2025/06/30

4.

Conestoga Capital Advisors, LLC

(4.3911%)

since

2025/06/30

5.

State Street Corp

(3.6458%)

since

2025/06/30

6.

iShares Core S&P Mid-Cap ETF

(3.2548%)

since

2025/08/31

7.

Vanguard Total Stock Mkt Idx Inv

(3.1592%)

since

2025/07/31

8.

Wasatch Advisors LP

(3.0579%)

since

2025/06/30

9.

US Small-Cap Growth II Equity Comp

(2.7545%)

since

2025/06/30

10.

Geneva Capital Management

(2.7491%)

since

2025/06/30

11.

William Blair Investment Management, LLC

(2.7239%)

since

2025/06/30

12.

T. Rowe Price New Horizons

(2.7193%)

since

2025/07/31

13.

Conestoga Small Cap Investors

(2.576%)

since

2025/07/31

14.

Geode Capital Management, LLC

(2.5565%)

since

2025/06/30

15.

Allspring Global Investments Holdings, LLC

(2.4883%)

since

2025/06/30

16.

Vanguard Small Cap Index

(2.428%)

since

2025/07/31

17.

iShares Russell 2000 ETF

(2.4055%)

since

2025/08/31

18.

Capital Research & Mgmt Co - Division 3

(2.0999%)

since

2025/06/30

19.

American Funds SMALLCAP World A

(2.0999%)

since

2025/06/30

20.

Macquarie Group Ltd

(2.0785%)

since

2025/06/30

21.

JPMorgan Chase & Co

(2.0082%)

since

2025/06/30

22.

Morgan Stanley - Brokerage Accounts

(1.9862%)

since

2025/06/30

23.

Champlain Investment Partners, LLC

(1.9311%)

since

2025/06/30

24.

Vanguard Information Technology ETF

(1.8124%)

since

2025/07/31

25.

Wasatch Core Growth

(1.722%)

since

2025/06/30

26.

Macquarie US Mid Cap Growth Equity

(1.6508%)

since

2025/06/30

27.

Macquarie Mid Cap Growth A

(1.6508%)

since

2025/07/31

28.

Dimensional Fund Advisors, Inc.

(1.6252%)

since

2025/06/30

29.

Neuberger Berman Group LLC

(1.4369%)

since

2025/06/30

30.

Vanguard Small Cap Growth Index Inv

(1.3668%)

since

2025/07/31

31.

Northern Trust Corp

(1.3404%)

since

2025/06/30

32.

Champlain Small Company Fund, LLC

(1.2663%)

since

2025/08/31

33.

Charles Schwab Investment Management Inc

(1.2542%)

since

2025/06/30

34.

T. Rowe Price Investment Management,Inc.

(1.2271%)

since

2025/06/30

35.

Conestoga Small Cap Growth

(1.2094%)

since

2025/06/30

36.

JPMorgan Small Cap Equity A

(1.1151%)

since

2025/07/31

37.

JPM US Small Cap Core-Composite

(1.1151%)

since

2025/06/30

38.

JPM Small Cap Equity-MA

(1.1151%)

since

2025/06/30

39.

Vanguard Institutional Extnd Mkt Idx Tr

(1.075%)

since

2025/07/31

40.

Fidelity Small Cap Index

(1.0066%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.94

Latest Release

Date

2025-09-30

EPS Actual

0.87

EPS Estimate

0.84

EPS Difference

0.03

Surprise Percent

3.5714%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(6)
Growth
Moderate Growth(5)
Momentum
Strong Momentum(6.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.